A novel method for simultaneously measuring boronophenylalanine uptake in brain tumor cells and number of cells using inductively coupled plasma atomic emission spectroscopy.

Boron neutron capture therapy (BNCT) combines neutron irradiation with boron compounds that are selectively uptaken by tumor cells. Boronophenylalanine (BPA) is a boron compound used to treat malignant brain tumors. The determination of boron concentration in cells is of great relevance to the field of BNCT.

Evaluation of Pharmacokinetics of Boronophenylalanine and Its Uptakes in Gastric Cancer.

Boron neutron capture therapy (BNCT), a cellular-level particle radiation therapy, combines boron compounds selectively delivered to tumor tissue with neutron irradiation. Boronophenylalanine (BPA) is a boron compound widely used in malignant melanoma, malignant brain tumors, and recurrent head and neck cancer. However, neither basic nor clinical research was reported for the treatment of gastric cancer using BPA.

Isolated/interacting Au islands on TiO NTs for the switching photocatalytic/photoelectrocatalytic degradation of refractory organic pollutants in wastewater.

A three-dimensional surface catalyst with isolated/interacting Au islands loaded on TiO nanotubes (Au/TiO NTs) was prepared for the switching photocatalytic/photoelectrocatalytic (PC/PEC) degradation of refractory organic wastewater, and shows prominent catalytic activity and favorable stability. The Au islands act as "electronic reservoirs" for prolonging the lifetime of photo-generated electron-hole pairs. The fundamental structures and morphologies of the Au/TiO NTs were determined by XRD, SEM, EDS, XPS and ICP-AES, and the optical properties were estimated by UV-vis DRS and photocurrent response curves.